Eli Lilly Buys Rights to Diabetes Drugs - Houston Chronicle

Eli Lilly Buys Rights to Diabetes Drugs Houston Chronicle, United States - 20 hours ago Both companies will take part in the currently planned midstage clinical trial of TT-223 in type 2 diabetes, and Lilly will responsible for further ... Lilly Licenses Diabetes Treatment From Transition Thera CNNMoney.com Transition Therapeutics Scores Lilly in Diabetes Pact (TTHI, LLY) 24/7 Wall St. Eli Lilly, Transition Therapeutics enter licensing, collaboration ... Forbes Genetic Engineering News (press release) - Pharmaceutical Business Review all 48 news articles